Ready for New Discoveries?

In vitro and ex vivo assays are essential for exploring immune function, elucidating mechanisms of action, and characterizing cellular phenotypes in controlled systems. They provide focused mechanistic insight and early efficacy data that guide confident preclinical decisions. At Redoxis, we design scientifically tailored assays aligned with your biological question, therapeutic modality, and development phase. From pathway modulation and cytokine profiling to advanced immune cell phenotyping, our work is grounded in translational relevance and immunological expertise. Integrated with our in vivo capabilities, our in vitro and ex vivo platforms generate cohesive, decision-enabling data — efficiently, rigorously, and in close collaboration with you.

In vivo models are critical for understanding therapeutic efficacy, disease mechanisms, and translational relevance in complex biological systems. They provide the functional validation needed to move confidently from discovery toward clinical development. At Redoxis, we specialize in well-characterized models of inflammation and autoimmune disease. Each study is thoughtfully designed around your mechanism of action, therapeutic modality, and development goals — ensuring biologically relevant and decision-enabling outcomes. Combined with our in vitro and ex vivo expertise, our in vivo services deliver integrated, high-quality data packages that reduce risk and strengthen your development strategy.

Advanced tissue analysis and high-resolution profiling are essential for translating biological effects into mechanistic insight. Histology, imaging, and single-cell sequencing provide spatial, cellular, and molecular depth — revealing how therapies modulate disease at tissue and cell-specific levels. At Redoxis, we combine quantitative histopathology, advanced imaging platforms, and single-cell transcriptomic analysis to deliver multidimensional data with translational relevance. From tissue architecture and immune infiltration to pathway-specific cellular signatures, our approaches strengthen mechanistic understanding and support confident decision-making. Fully integrated with our in vivo and in vitro services, these technologies complete the picture — enabling robust, data-driven progression of your preclinical program.